09/09/2026
What if one ultra-rare diagnosis could help unlock answers for many more?
That is the hope of CAGS research.
Chopra-Amiel-Gordon Syndrome (CAGS) is caused by changes in the ANKRD17 gene. Two physicians who helped discover and describe CAGS now serve on our Scientific & Medical Advisory Committee, including Dr. Maya Chopra of Boston Children’s Hospital, a global leader in pediatric medical and neurological research.
Through the CAGS Foundation, our growing global community, and the CAGS Clinic at Boston Children’s, families connect directly with the clinicians and scientists who have been studying CAGS from the beginning.
This collaboration is helping build a stronger foundation for discovery and the potential impact extends far beyond CAGS.
Research on ANKRD17 may deepen understanding of genetic epilepsies, neurodevelopmental disorders, neurological syndromes, and treatments for rare genetic diseases. Discoveries in one rare disorder can generate knowledge and tools that benefit many others.
We have the community.
We have the expertise.
We have the team.
Now we need your support to keep the science moving.
Visit https://curecags.org to donate today. Your gift can accelerate research, support families, and advance the search for better treatments.
Please give now and help turn the promise of CAGS research into progress.
Cure CAGS is dedicated to finding treatments and a cure for ANKRD17 Chopra-Amiel-Gordon Syndrome. Join our global network to support research and connect with others affected by this rare condition.